Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Xin-an Lu, Dr
CONTACT
Lead
Beijing Immunochina Medical Science & Technology Co., Ltd.
With
1. Dose-escalation:Patients entered the IM19-41BB or IM19-CD28 group and performed dose escalation studies in three dose groups. 2. According to the results of the previous dose escalation study, select one dose to continue the enrollment of 6 patients for extended studies.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted